Quantitative accuracy of MAP reconstruction for dynamic PET imaging in small animals.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 3281972)

Published in Med Phys on February 01, 2012

Authors

Ju-Chieh Kevin Cheng1, Kooresh Shoghi, Richard Laforest

Author Affiliations

1: Washington University School of Medicine, St. Louis, MO 63110, USA.

Articles cited by this

Maximum likelihood reconstruction for emission tomography. IEEE Trans Med Imaging (1982) 11.17

High-resolution 3D Bayesian image reconstruction using the microPET small-animal scanner. Phys Med Biol (1998) 5.47

Exact and approximate rebinning algorithms for 3-D PET data. IEEE Trans Med Imaging (1997) 3.65

Performance measurement of the microPET focus 120 scanner. J Nucl Med (2007) 2.10

Evaluation of iterative reconstruction (OSEM) versus filtered back-projection for the assessment of myocardial glucose uptake and myocardial perfusion using dynamic PET. Eur J Nucl Med Mol Imaging (2006) 1.53

Measurement of input functions in rodents: challenges and solutions. Nucl Med Biol (2005) 1.50

Statistical dynamic image reconstruction in state-of-the-art high-resolution PET. Phys Med Biol (2005) 1.50

Minimally invasive method of determining blood input function from PET images in rodents. J Nucl Med (2006) 1.46

Bayesian reconstruction of PET images: methodology and performance analysis. Phys Med Biol (1996) 1.45

Comparison of 3-D maximum a posteriori and filtered backprojection algorithms for high-resolution animal imaging with microPET. IEEE Trans Med Imaging (2000) 1.44

Estimation of the 18F-FDG input function in mice by use of dynamic small-animal PET and minimal blood sample data. J Nucl Med (2007) 1.42

Noise and signal properties in PSF-based fully 3D PET image reconstruction: an experimental evaluation. Phys Med Biol (2010) 1.39

Experimental and clinical evaluation of iterative reconstruction (OSEM) in dynamic PET: quantitative characteristics and effects on kinetic modeling. J Nucl Med (2001) 1.36

Factor analysis for extraction of blood time-activity curves in dynamic FDG-PET studies. J Nucl Med (1995) 1.36

Four-dimensional (4D) image reconstruction strategies in dynamic PET: beyond conventional independent frame reconstruction. Med Phys (2009) 1.31

In vivo quantitation of glucose metabolism in mice using small-animal PET and a microfluidic device. J Nucl Med (2007) 1.30

Image-quality assessment for several positron emitters using the NEMA NU 4-2008 standards in the Siemens Inveon small-animal PET scanner. J Nucl Med (2010) 1.30

Theoretical study of lesion detectability of MAP reconstruction using computer observers. IEEE Trans Med Imaging (2001) 1.29

Image-based point spread function implementation in a fully 3D OSEM reconstruction algorithm for PET. Phys Med Biol (2010) 1.24

Joint estimation of dynamic PET images and temporal basis functions using fully 4D ML-EM. Phys Med Biol (2006) 1.23

Comparison of 3-D reconstruction with 3D-OSEM and with FORE+OSEM for PET. IEEE Trans Med Imaging (2001) 1.18

Hybrid image and blood sampling input function for quantification of small animal dynamic PET data. Nucl Med Biol (2007) 1.12

A survey of approaches for direct parametric image reconstruction in emission tomography. Med Phys (2008) 1.08

Derivation of input function from FDG-PET studies in small hearts. J Nucl Med (1996) 1.08

Bias in iterative reconstruction of low-statistics PET data: benefits of a resolution model. Phys Med Biol (2011) 1.04

Accuracy of 3-dimensional reconstruction algorithms for the high-resolution research tomograph. J Nucl Med (2008) 1.04

Iterative image reconstruction using inverse Fourier rebinning for fully 3-D PET. IEEE Trans Med Imaging (2007) 1.04

Arterial input function measurement without blood sampling using a beta-microprobe in rats. J Nucl Med (2004) 0.99

The application of maximum likelihood factor analysis (MLFA) with uniqueness constraints on dynamic cardiac microPET data. Phys Med Biol (2007) 0.98

Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides. Nucl Med Biol (2006) 0.96

Effect of reconstruction algorithms on myocardial blood flow measurement with 13N-ammonia PET. J Nucl Med (2007) 0.90

Theoretical evaluation of the detectability of random lesions in Bayesian emission reconstruction. Inf Process Med Imaging (2003) 0.82

OS-EM and FBP reconstructions at low count rates: effect on 3D PET studies of [11C] WAY-100635. Neuroimage (2004) 0.82

Articles by these authors

Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging. J Nucl Med (2005) 4.79

Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recognit (2009) 3.32

In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM. Eur J Nucl Med Mol Imaging (2003) 2.25

Gold nanocages as photothermal transducers for cancer treatment. Small (2010) 1.92

Registration of [18F]FDG microPET and small-animal MRI. Nucl Med Biol (2005) 1.89

Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart. J Clin Invest (2007) 1.88

Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med (2008) 1.51

Minimally invasive method of determining blood input function from PET images in rodents. J Nucl Med (2006) 1.46

Instrumentation aspects of animal PET. Annu Rev Biomed Eng (2005) 1.40

NEMA NU 4-2008 comparison of preclinical PET imaging systems. J Nucl Med (2012) 1.38

Multimodal imaging of integrin receptor-positive tumors by bioluminescence, fluorescence, gamma scintigraphy, and single-photon emission computed tomography using a cyclic RGD peptide labeled with a near-infrared fluorescent dye and a radionuclide. Mol Imaging (2009) 1.27

18F-fluoroacetate: a potential acetate analog for prostate tumor imaging--in vivo evaluation of 18F-fluoroacetate versus 11C-acetate. J Nucl Med (2007) 1.25

An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix. J Nucl Med (2008) 1.18

Preparation of high specific activity (86)Y using a small biomedical cyclotron. Nucl Med Biol (2005) 1.10

Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone). J Nucl Med (2002) 1.09

Diels-Alder reaction for tumor pretargeting: in vivo chemistry can boost tumor radiation dose compared with directly labeled antibody. J Nucl Med (2013) 1.06

Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals. Nucl Med Biol (2003) 1.03

A novel PET tumor delineation method based on adaptive region-growing and dual-front active contours. Med Phys (2008) 1.02

Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides. Nucl Med Biol (2006) 0.96

Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione. J Nucl Med (2012) 0.92

Assessment of cellular proliferation in tumors by PET using 18F-ISO-1. J Nucl Med (2013) 0.90

Production and purification of gallium-66 for preparation of tumor-targeting radiopharmaceuticals. Nucl Med Biol (2002) 0.89

Nuclear uptake and dosimetry of 64Cu-labeled chelator somatostatin conjugates in an SSTr2-transfected human tumor cell line. J Nucl Med (2007) 0.89

Physiologic FDG-PET three-dimensional brachytherapy treatment planning for cervical cancer. Int J Radiat Oncol Biol Phys (2002) 0.89

Quantitative small animal PET imaging with nonconventional nuclides. Nucl Med Biol (2009) 0.87

Advances in the production, processing and microPET image quality of technetium-94m. Nucl Med Biol (2006) 0.84

Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates. Eur J Nucl Med Mol Imaging (2007) 0.84

PET-guided three-dimensional treatment planning of intracavitary gynecologic implants. Int J Radiat Oncol Biol Phys (2002) 0.83

Initial characterization of a dually radiolabeled peptide for simultaneous monitoring of protein targets and enzymatic activity. Nucl Med Biol (2012) 0.83

The role of p53 in combination radioimmunotherapy with 64Cu-DOTA-cetuximab and cisplatin in a mouse model of colorectal cancer. J Nucl Med (2013) 0.82

Radiochemical synthesis, rodent biodistribution and tumor uptake, and dosimetry calculations of [¹¹C] methylated LY2181308. Mol Imaging Biol (2010) 0.79

In vivo multi-tissue efficacy of peroxisome proliferator-activated receptor-γ therapy on glucose and fatty acid metabolism in obese type 2 diabetic rats. Obesity (Silver Spring) (2013) 0.79

Sequential FDG-PET brachytherapy treatment planning in carcinoma of the cervix. Int J Radiat Oncol Biol Phys (2005) 0.79

Beyond whole-body imaging: advanced imaging techniques of PET/MRI. Clin Nucl Med (2015) 0.78

Feasibility and dosimetry studies for 18F-NOS as a potential PET radiopharmaceutical for inducible nitric oxide synthase in humans. J Nucl Med (2012) 0.78

Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer's disease. EJNMMI Res (2015) 0.77

Production, processing and small animal PET imaging of titanium-45. Nucl Med Biol (2005) 0.77

Dual-radiolabeled nanoparticle SPECT probes for bioimaging. Nanoscale (2015) 0.77

Demonstration of intermittent ischemia and stunning in hibernating myocardium. J Nucl Cardiol (2013) 0.76

A scatter and randoms weighted (SRW) iterative PET reconstruction. Med Phys (2011) 0.75